Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate: Apparent Diffusion Coefficient in the Evaluation of Therapy Response in Patients - Concepedia

Concepedia

Publication | Closed Access

Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate: Apparent Diffusion Coefficient in the Evaluation of Therapy Response in Patients

51

Citations

26

References

2010

Year

Lei Tang, Xiao Peng Zhang, Ying‐Shi Sun, Lin Shen, Jian Li, Liping Qi, Yong Cui

Abstract

Comparatively low pretherapy ADC and marked ADC increase at 1 week after therapy is associated with good response to imatinib mesylate in patients with GISTs.

References

	Year	Citations

Page 1